GSK1838262 Extended Release Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK1838262 Extended Release Tablets, covering 2011-05-18 to 2011-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance [Phase 3]